BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11306834)

  • 21. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS; Laird N
    Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA.
    Eskelinen A; Halme K; Lassus A; Idänpään-Heikkilä J
    Photodermatol; 1985 Feb; 2(1):10-4. PubMed ID: 3982991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients.
    Euvrard S; Chardonnet Y; Pouteil-Noble C; Kanitakis J; Chignol MC; Thivolet J; Touraine JL
    Cancer; 1993 Oct; 72(7):2198-206. PubMed ID: 8397062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of multiple spinocellular cancer of the skin in a patient with psoriasis].
    Rubins AIa; Raevskaia AS; Vikmanis UE; Rozhkalns VV; Poluéktova LE
    Vestn Dermatol Venerol; 1989; (3):72-4. PubMed ID: 2741553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UV-A.
    Wolf P; Seidl H; Bäck B; Binder B; Höfler G; Quehenberger F; Hoffmann C; Kerl H; Stark S; Pfister HJ; Fuchs PG
    Arch Dermatol; 2004 Mar; 140(3):317-24. PubMed ID: 15023775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple malignant changes and recurrent infections in the skin associated with long-term exposure to ultraviolet light and topical psoralen plus ultraviolet A therapy.
    Hirose-Matsuda H; Okamoto O; Sakai T; Ito A; Kai Y; Hatano Y; Hanada K; Yamaoka Y; Fujiwara S
    J Dermatol; 2015 May; 42(5):536-7. PubMed ID: 25772404
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple squamous cell carcinomas in situ in vitiligo lesions after long-term PUVA therapy.
    Takeda H; Mitsuhashi Y; Kondo S
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):268-70. PubMed ID: 9486686
    [No Abstract]   [Full Text] [Related]  

  • 28. Skin cancer in the PUVA-48 cooperative study.
    Roenigk HH; Caro WA
    J Am Acad Dermatol; 1981 Mar; 4(3):319-24. PubMed ID: 7217399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus type 11 in multiple squamous cell carcinomas in a patient with subacute cutaneous lupus erythematosus.
    Cohen LM; Tyring SK; Rády P; Callen JP
    J Am Acad Dermatol; 1992 May; 26(5 Pt 2):840-5. PubMed ID: 1319432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
    Stern RS; Lunder EJ
    Arch Dermatol; 1998 Dec; 134(12):1582-5. PubMed ID: 9875197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS;
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
    Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
    Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).
    Nataraj AJ; Wolf P; Cerroni L; Ananthaswamy HN
    J Invest Dermatol; 1997 Aug; 109(2):238-43. PubMed ID: 9242514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
    Maiorino A; De Simone C; Perino F; Caldarola G; Peris K
    J Dermatolog Treat; 2016 Oct; 27(5):443-7. PubMed ID: 26822468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.
    Bruynzeel I; Bergman W; Hartevelt HM; Kenter CC; Van de Velde EA; Schothorst AA; Suurmond D
    Br J Dermatol; 1991 Jan; 124(1):49-55. PubMed ID: 1993145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.
    Connolly K; Manders P; Earls P; Epstein RJ
    Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PUVA and cancer: a case-control study.
    Lindelöf B; Sigurgeirsson B
    Br J Dermatol; 1993 Jul; 129(1):39-41. PubMed ID: 8369208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous carcinoma in psoriatic patients treated with PUVA.
    Reshad H; Challoner F; Pollock DJ; Baker H
    Br J Dermatol; 1984 Mar; 110(3):299-305. PubMed ID: 6696845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.